Neurocrine Biosciences Inc (NASDAQ:NBIX)

51.92
Delayed Data
As of Jul 28
 +2.58 / +5.23%
Today’s Change
13.11
Today|||52-Week Range
56.18
+132.41%
Year-to-Date

Today’s Trading

Previous close49.34
Today’s open49.89
Day’s range-- - --
Volume607,555
Average volume (3 months)939,947
Market cap$4.2B
Dividend yield--
Data as of 07/28/2015

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)-3.86%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book18.08

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA+0.04+0.13%
RAREUltragenyx Pharmaceu...+3.54+3.02%
ACADACADIA Pharmaceutica...+1.74+3.66%
IPXLImpax Laboratories I...0.000.00%
Data as of 07/28/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$60.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers